Journal of Cardiovascular Emergencies (Dec 2020)

Effectiveness of Different P2Y12 Inhibitors on Coronary Flow in Patients with ST-Elevation Myocardial Infarction

  • Seker Onur Osman,
  • Cerik Idris Bugra,
  • Coksevim Metin,
  • Yenercag Mustafa,
  • Soylu Korhan

DOI
https://doi.org/10.2478/jce-2020-0018
Journal volume & issue
Vol. 6, no. 4
pp. 91 – 97

Abstract

Read online

Background: ST-segment elevation myocardial infarction (STEMI) is a clinical syndrome with high mortality. The main purpose of STEMI treatment is to achieve optimal revascularization for tissue perfusion. Besides the innovations in revascularization strategies, developments in antithrombotic therapy resulted in a significant reduction in STEMI-related mortality. Reperfusion can be demonstrated by resolution of ST-segment elevation (STR), TIMI frame count (TFC), and myocardial blush grade (MBG). Aim of the study: In our study, we investigated the effects of P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor on reperfusion parameters such as TFC, MBG, and STR, after primary percutaneous coronary intervention (pPCI) in STEMI.

Keywords